UNSPSC 51192500: Combination prostaglandins

This classification denotes combination drugs and preparations in at least one constituient derives from unsaturated 20-carbon fatty acids, primarily arachidonic acid, via the cyclooxygenase pathway, so called as PROSTA-GLANDINS or PROSTAGLANDINS because scientists first isolated and later synthesized these from the human prostate gland. Typical combination prostaglandin constituients are carboprost and tromethamine.

UNSPSC 51192500 Combination prostaglandins is a Class code that, despite its nominal scope, captures state and local government procurement of generic multi-source pharmaceuticals and over-the-counter products distributed across facilities in participating jurisdictions. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is the primary issuing body active under this code, soliciting manufacturers to supply comprehensive pharmaceutical product lines with specified National Drug Codes, pricing flexibility across multiple formats (flat price, net price variants, and WAC-minus structures), and compliance with cGMP, the Drug Supply Chain Security Act, and FDA requirements. Vendors must maintain contractual relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation / Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) and carry insurance including $5,000,000 commercial general liability and $2,000,000 network security and privacy liability. Products must be available in the marketplace by May 15, 2026, with resulting contract terms of two years for new vendors through June 30, 2028.

MMCAP's January 20, 2026 RFP for Generic Multi Source Pharmaceuticals and OTC Products represents the recent activity under this code, extending across Minnesota and Oregon with responses due March 26, 2026. Evaluation weighting emphasizes price competitiveness at 75 percent, with the remaining 25 percent distributed across fixed pricing, administrative compliance, EDI capability, and agreement to a 3 percent administrative fee; vendors face performance penalties ranging from $200 to $1,500 per violation. No specific dollar values or budget ranges are disclosed, and MMCAP reserves the right to make sole, dual, or multi-awards based on therapeutic considerations and member-specific needs. Questions close February 18, 2026.